Safety and Efficacy Study of Angiotensin Therapeutic Vaccine in Subjects With Mild to Moderate Hypertension

Clinical trial NCT00702221 · TERMINATED

Trial details

NCT number: NCT00702221
Sponsor: BTG International Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension Cardiovascular Disease

Start date: 2008-06-01
Primary completion: 2009-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.